MIFF 发表于 2025-3-21 20:07:59

书目名称Cancer Immunotherapies影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0221136<br><br>        <br><br>书目名称Cancer Immunotherapies影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0221136<br><br>        <br><br>书目名称Cancer Immunotherapies网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0221136<br><br>        <br><br>书目名称Cancer Immunotherapies网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0221136<br><br>        <br><br>书目名称Cancer Immunotherapies被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0221136<br><br>        <br><br>书目名称Cancer Immunotherapies被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0221136<br><br>        <br><br>书目名称Cancer Immunotherapies年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0221136<br><br>        <br><br>书目名称Cancer Immunotherapies年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0221136<br><br>        <br><br>书目名称Cancer Immunotherapies读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0221136<br><br>        <br><br>书目名称Cancer Immunotherapies读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0221136<br><br>        <br><br>

lobster 发表于 2025-3-21 21:18:16

http://reply.papertrans.cn/23/2212/221136/221136_2.png

EVADE 发表于 2025-3-22 03:22:36

http://reply.papertrans.cn/23/2212/221136/221136_3.png

死亡 发表于 2025-3-22 07:15:22

Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma,efficacy and safety of CAR T cell therapy in GBM. In this review, common challenges associated with treating GBM will be discussed in addition to how CAR T cells can overcome such barriers. Additionally, emerging techniques of optimizing CAR T cell therapy for GBM will be emphasized, highlighting the prospective promise of cellular immunotherapy.

懒洋洋 发表于 2025-3-22 10:11:33

http://reply.papertrans.cn/23/2212/221136/221136_5.png

知识分子 发表于 2025-3-22 14:14:34

http://reply.papertrans.cn/23/2212/221136/221136_6.png

知识分子 发表于 2025-3-22 19:48:02

http://reply.papertrans.cn/23/2212/221136/221136_7.png

过多 发表于 2025-3-22 22:46:33

http://reply.papertrans.cn/23/2212/221136/221136_8.png

Compassionate 发表于 2025-3-23 03:57:47

Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity,rticularly with the goal of generating Th1-promoting inflammation that stokes endogenous priming of antitumor CD8. T cells, is a growing area of clinical investigation. This approach is analogous to in situ vaccination, ultimately providing a personalized antitumor response against relevant tumor as

Exuberance 发表于 2025-3-23 05:47:12

http://reply.papertrans.cn/23/2212/221136/221136_10.png
页: [1] 2 3 4 5
查看完整版本: Titlebook: Cancer Immunotherapies; Solid Tumors and Hem Priya Hays Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusive license